T helper (Th)1 cells were considered responsible for the induction of graft-versus-host disease (GVHD), but recently the concept has been challenged. Th17 cells play a critical role in mediating autoimmune diseases, but their role in the pathogenesis of GVHD remains unclear. Herein we compare the ability of in vitro generated Th1 and Th17 cells from C57BL/6 mice to induce GVHD in lethally irradiated BALB/c recipients. Allogeneic Th17 cells had superior expansion and infiltration capabilities in GVHD target organs, which correlated with their increased pathogenicity when compared with naïve or Th1 controls. Th17 cells caused no pathology in the syngeneic recipients, indicating that antigen-activation was required for their pathogenicity. Pol...
AbstractThe role of Th17 cells and Th17-associated cytokines in the development of acute graft-versu...
Item does not contain fulltextGraft-versus-host disease (GVHD) is still a major complication of allo...
Graft-versus-Host-Disease (GVHD) is still the major obstacle for the widespread application of allog...
T helper (Th)1 cells were considered responsible for the induction of graft-versus-host disease (GVH...
AbstractGraft-versus-host disease (GVHD) is still a major complication of allogeneic stem cell trans...
The limitations of allogeneic transplantation are graft-versus-host disease (both acute and chronic)...
Th17 is a newly identified T-cell lineage that secretes proinflammatory cytokine IL-17. Th17 cells h...
Graft-versus-host disease (GvHD) remains the most significant complication after allogeneic stem cel...
The transition from acute to chronic graft-versus-host disease (aGVHD, cGVHD) is characterized by th...
AbstractRegulatory T cell (Treg) immunotherapy is a promising strategy for the treatment of graft re...
IL-17–producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
IL-17–producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
IL-17-producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
AbstractInterleukin 17A (IL-17)-producing CD4+ T helper type 17 (Th17) cells have recently drawn att...
OBJECTIVES: Graft-versus-host disease (GVHD) is a major obstacle to safe allogeneic hematopoietic st...
AbstractThe role of Th17 cells and Th17-associated cytokines in the development of acute graft-versu...
Item does not contain fulltextGraft-versus-host disease (GVHD) is still a major complication of allo...
Graft-versus-Host-Disease (GVHD) is still the major obstacle for the widespread application of allog...
T helper (Th)1 cells were considered responsible for the induction of graft-versus-host disease (GVH...
AbstractGraft-versus-host disease (GVHD) is still a major complication of allogeneic stem cell trans...
The limitations of allogeneic transplantation are graft-versus-host disease (both acute and chronic)...
Th17 is a newly identified T-cell lineage that secretes proinflammatory cytokine IL-17. Th17 cells h...
Graft-versus-host disease (GvHD) remains the most significant complication after allogeneic stem cel...
The transition from acute to chronic graft-versus-host disease (aGVHD, cGVHD) is characterized by th...
AbstractRegulatory T cell (Treg) immunotherapy is a promising strategy for the treatment of graft re...
IL-17–producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
IL-17–producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
IL-17-producing cells are important mediators of graft-versus-host disease (GVHD) after allogeneic s...
AbstractInterleukin 17A (IL-17)-producing CD4+ T helper type 17 (Th17) cells have recently drawn att...
OBJECTIVES: Graft-versus-host disease (GVHD) is a major obstacle to safe allogeneic hematopoietic st...
AbstractThe role of Th17 cells and Th17-associated cytokines in the development of acute graft-versu...
Item does not contain fulltextGraft-versus-host disease (GVHD) is still a major complication of allo...
Graft-versus-Host-Disease (GVHD) is still the major obstacle for the widespread application of allog...